Interleukin-22, liver progenitor cells, and liver cancer

Hepatology

Volumn 60, Issue 1, 2014, Pages 427-428

  Feng, Dechun ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; HEPATITIS B VIRUS X PROTEIN; INTERLEUKIN 22; STAT3 PROTEIN;

CANCER PROGNOSIS; CARCINOGENICITY; CELL EXPANSION; GENE TARGETING; HUMAN; LETTER; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PROGENITOR CELL; LIVER PROTECTION; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR GROWTH; VIRUS HEPATITIS; WILD TYPE;

ANIMALS; HUMANS; INTERLEUKINS; LIVER; LIVER NEOPLASMS; PROGNOSIS; STEM CELLS;

EID: 84903122746     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26899     Document Type: Letter

References (6)

1. Jiang R, Zhang C, Xia Y, Qian X, Wang X, Sun B. Reply to serum interleukin-22 levels are a negative prognostic indicator in patients with hepatocellular carcinoma. Hepatology 2014;59:1208.
2. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332-1342.
3. Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011;54:900-909.
4. Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 2011;54:252-261.
5. Feng D, Kong X, Weng H, Park O, Wang H, Dooley S, et al. Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 2012;143:188-198.e7.
6. Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, et al. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine-treated HBx transgenic mice. Hepatology 2012;55:108-120.